Cargando…

Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes

Background: Although ceramides are involved in the pathophysiology of cardiovascular disease and other inflammation-associated disorders, there is a paucity of data on the association between plasma ceramides and inflammatory biomarkers in type 2 diabetes mellitus (T2DM). Therefore, we explored whet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mantovani, Alessandro, Csermely, Alessandro, Sani, Elena, Beatrice, Giorgia, Petracca, Graziana, Lunardi, Gianluigi, Bonapace, Stefano, Lippi, Giuseppe, Targher, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312999/ https://www.ncbi.nlm.nih.gov/pubmed/35883498 http://dx.doi.org/10.3390/biom12070943

Ejemplares similares

Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2020)

Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Relation between plasma ceramides and cardiovascular death in chronic heart failure: A subset analysis of the GISSI‐HF trial
por: Targher, Giovanni, et al.
Publicado: (2020)

Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study
por: Mantovani, Alessandro, et al.
Publicado: (2022)

Nonalcoholic fatty liver disease is associated with an increased risk of heart block in hospitalized patients with type 2 diabetes mellitus
por: Mantovani, Alessandro, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease Is Associated with Aortic Valve Sclerosis in Patients with Type 2 Diabetes Mellitus
por: Bonapace, Stefano, et al.
Publicado: (2014)

Left ventricular chamber dilation and filling pressure may help to categorise patients with type 2 diabetes
por: Zoppini, Giacomo, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease Is Independently Associated with Early Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2015)

Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection
por: Kajimoto, Etsuko, et al.
Publicado: (2020)

Research Progress on Leucine-Rich Alpha-2 Glycoprotein 1: A Review
por: Zou, Yonghui, et al.
Publicado: (2022)

Leucine-Rich Alpha-2-Glycoprotein: A Novel Predictor of Diastolic Dysfunction
por: Loch, Alexander, et al.
Publicado: (2023)

Plasma Bile Acid Profile in Patients with and without Type 2 Diabetes
por: Mantovani, Alessandro, et al.
Publicado: (2021)

Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus
por: Nakajima, Madoka, et al.
Publicado: (2011)

Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma
por: Honda, Hiromi, et al.
Publicado: (2016)

Leucine-rich alpha 2 glycoprotein is a new marker for active disease of tuberculosis
por: Fujimoto, Minoru, et al.
Publicado: (2020)

Leucine-rich alpha-2-glycoprotein 1 and angiotensinogen as diagnostic biomarkers for Kawasaki disease
por: Yanagimachi, Masakatsu, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a potential biomarker for large vessel vasculitides
por: Umezawa, Natsuka, et al.
Publicado: (2023)

Leucine-Rich Alpha-2 Glycoprotein 1 Accumulates in Complicated Atherosclerosis and Promotes Calcification
por: Grzesiak, Lucile, et al.
Publicado: (2023)

Increased Pulse Pressure Independently Predicts Incident Atrial Fibrillation in Patients With Type 2 Diabetes
por: Valbusa, Filippo, et al.
Publicado: (2012)

Non-Alcoholic Fatty Liver Disease Is Associated with an Increased Incidence of Atrial Fibrillation in Patients with Type 2 Diabetes
por: Targher, Giovanni, et al.
Publicado: (2013)

Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
por: Andersen, John D, et al.
Publicado: (2010)

Leucine Rich α-2 Glycoprotein: A Novel Neutrophil Granule Protein and Modulator of Myelopoiesis
por: Druhan, Lawrence J., et al.
Publicado: (2017)

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
por: Shinzaki, Shinichiro, et al.
Publicado: (2017)

Leucine-rich α2-glycoprotein-1 upregulation in plasma and kidney of patients with lupus nephritis
por: Yang, Yi, et al.
Publicado: (2020)

Leucine-rich alpha-2-glycoprotein 1 (LRG1) as a novel ADC target
por: Javaid, Faiza, et al.
Publicado: (2021)

The Prognostic Value of Leucine-Rich α2 Glycoprotein 1 in Pediatric Spinal Cord Injury
por: Ma, Hong, et al.
Publicado: (2021)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
por: Yasutomi, Eriko, et al.
Publicado: (2021)

Diagnostic Utility of Serum Leucine-Rich α-2-Glycoprotein 1 for Acute Appendicitis in Children
por: Tintor, Goran, et al.
Publicado: (2023)

Serum leucine‐rich α2‐glycoprotein as a possible marker for inflammatory status in endometriosis
por: Kobayashi, Mio, et al.
Publicado: (2023)

Increased aortic stiffness in adults with chronic indeterminate Chagas disease
por: Valbusa, Filippo, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
por: Valbusa, Filippo, et al.
Publicado: (2017)

Leucine‐rich α‐2 glycoprotein promotes lung fibrosis by modulating TGF‐β signaling in fibroblasts
por: Honda, Hiromi, et al.
Publicado: (2017)

Leucine-rich alpha-2-glycoprotein-1 is up-regulated in colorectal cancer and is a tumor promoter
por: Zhang, Qian, et al.
Publicado: (2018)

Up-regulation of the expression of leucine-rich α(2)-glycoprotein in hepatocytes by the mediators of acute-phase response
por: Shirai, Ryoichi, et al.
Publicado: (2009)

Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis
por: Matsumoto, Satohiro, et al.
Publicado: (2022)

Serum leucine-rich α2 glycoprotein as a potential biomarker for systemic inflammation in Parkinson’s disease
por: Ohmichi, Takuma, et al.
Publicado: (2023)

Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
por: Otsuru, Toru, et al.
Publicado: (2019)

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure
por: Inciardi, Riccardo M., et al.
Publicado: (2023)

Listen to your heart when ceramide's calling for higher glucose
por: Wilkerson, Joseph L., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hneh7f7q6ttf9sc205nmdigdu4